On June 15, 2020, the United States Patent & Trademark Office (USPTO) launched a new COVID-19 prioritized examination program. The USPTO will advance the initial examination of applications for marks used to identify qualifying COVID-19 medical products and services, and will waive the fee for these petitions.

See this notice for more information on qualifying COVID-19 medical products and services.

If you have any questions about protecting your intellectual property, please contact a member of our Taft Intellectual Property practice.

Please visit our COVID-19 Toolkit for all of Taft’s updates on the coronavirus.